Roland Martin, MD
Head of nims Email: roland.martin@usz.ch Tel (secretary): +41 44 255 12 18 |
Roland Martin is full professor for neurology and neuroimmunology at the University Zürich and heads the Neuroimmunology and Multiple Sclerosis Research Section and MS outpatient clinic at the University Hospital Zurich. R. Martin trained in medicine, and specialized in neurology at the University Würzburg. He pursued post-doctoral fellowships in immunology, virology and neuroimmunology in Würzburg and at the Neuroimmunology Branch, National Institutes of Health (NIH), Bethesda, USA, where he worked as tenured senior investigator until 2005. Subsequently, he held full professorships in Barcelona (Vall D´Hebron University Hospital), Hamburg (Director of the Institute for Neuroimmunology and Clinical MS Research, University Hamburg) and now in Zurich. The main interests of his group are disease mechanisms of multiple sclerosis (MS), cellular immunology, disease mechanisms of JC polyoma virus-mediated progressive multifocal leukoencephalopathy (PML) and developing novel treatments for MS and PML besides providing care for MS patients in one of the largest MS centers in Switzerland. He has received several awards (2001 Julius Stone Lectureship Award of Society of Investigative Dermatology; 2000 NIH Director’s Award, 1994-96 Heisenberg Research Professorship of the German Research Society; 1995 Heinrich Pette Award of the German Neurological Society, 1993 and 2000 NIH Special Service Award), published over 390 scientific articles and filed numerous patents in the above areas. He and his group developed more than 10 projects from idea to early clinical proof-of-concept trials. He is a member of the Kuratorium of the Jung Foundation for Science, Hamburg, of the core faculty of the Wyss Translational Center Zurich, a cofounder of the Drug Discovery Network Zurich (DDNZ), a cofounder of the Therapy Development Accelerator (TDA) at the University Zurich, and a cofounder and co-owner of Cellerys AG, a startup company specializing in tolerance induction.
https://scholar.google.ch/citations?user=Iio7blEAAAAJ&hl=de&oi=ao |
Third Party Funding
Mireia Sospedra Ramos, PhD
Head of nims laboratory Email: mireia.sospedraramos@usz.ch Tel: +41 44 255 39 05 |
Mireia Sospedra studied biology at the University of Barcelona and received her PhD on the induction of central tolerance to peripheral antigens at the Autonomous University of Barcelona under the supervision of Dr. Ricardo Pujol Borrell. After her PhD she moved to Paris in 1999 where she pursued a first postdoc at la Pitié-Salpêtrière hospital under the supervision of Dr. Alain Trautmann studying the interaction between T cells and dendritic cells in the absence of nominal antigen. In April 2001 she obtained a competitive fellowship from the National Institute of Neuological Diseases and Stroke (NINDS; at the National Institute of Health (NIH)) and moved to USA for a second postdoc. She started working in MS under the supervision of Dr. Roland Martin with a focus on the identification of new autoantigens. After four years at NIH, she returned to Barcelona 2005 with a career development grant/assistant professorship of the Catalan Institute for Research and Advanced Studies (ICREA) at the Neuroimmunology Unit (Vall d’Hebron Hospital) directed by Dr. Xavier Montalban. In 2007 she moved to Hamburg and started working at Institute of Neuroimmunology and Multiple Sclerosis Research (Center of Molecular Neurobiology Hamburg, University Hospital Eppendorf) as independent investigator studying T cell specificity in MS and also the role of neutrophils. Since September 2011 she heads the Laboratory of Neuroimmunology at the Neuroimmunology and Multiple Sclerosis Research Section at the Neurology Clinic, University Hospital Zurich, and University of Zurich.
https://scholar.google.ch/citations?user=SA1_3pIAAAAJ&hl=de&oi=ao |
Third Party Funding
Ilijas Jelcic, MD
Head of MS outpatient clinic, aHSCT-in-MS service and CSF laboratory Ilijas.jelcic@usz.ch |
Ilijas Jelcic is a senior physician at the Neuroimmunology and MS Research Section (nims), Department of Neurology, University Hospital Zurich, and heads the Neuroimmunology outpatient clinic, the neurological day clinic, the aHSCT-in-MS service (autologous hematopoietic stem cell transplantation in multiple sclerosis) and the cerebrospinal fluid (CSF) laboratory of the Department of Neurology. He finished Medical School at Heidelberg University, Germany, and completed his medical doctoral thesis at the Division of Characterization of Tumor Viruses, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany. In a postdoctoral phase between 2006 and 2009, he pursued a “Deutsche Forschungsgemeinschaft” (DFG) research fellowship at the Institute for Neuroimmunology and Clinical Multiple Sclerosis Research (INiMS), Center for Molecular Neurobiology Hamburg (ZMNH), Germany, and completed a Graduate Program in Molecular Biology at ZMNH, University of Hamburg, Germany. He continued his training and research in Neurology at the Department of Neurology at the University Hospital Zurich and was board-certified in Neurology in 2018. His main research interests are autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis, cerebrospinal fluid diagnostics in multiple sclerosis and other neuroimmunological disorders, as well as diagnostic and therapeutical approaches in JC virus-caused progressive multifocal leukoencephalopathy (PML) and other neuroinfectious diseases.
Publication list J. Jelcic |
